medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2015, Number 4

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2015; 31 (4)

Epidemiology of transfusions at Central Military Hospital “Dr. Carlos J. Finlay”

Gil AM, García MA, Romero GA, Arias GL, Prevot CV, Sorá PD

Language: Spanish
References: 31
Page: 444-451
PDF size: 110.77 Kb.


ABSTRACT

Introduction: blood transfusion is the most common tissue transplantation today. Its therapeutic use has been part of the hospital therapy for more than a half a century. The development of contemporary medicine and population aging are cited as the main factors that increase the consumption of blood components.
Objective: to describe the epidemiology of blood transfusions at Dr. Carlos J. Finlay Central Military Hospital.
Methods: retrospective, descriptive cohort study was carried out and the total number of transfusions performed during 2013 was taken into account. The medical records and transfusion orders were reviewed to identify the consumption of blood components and their major indications, as well as the adverse reactions.
Results: atotal of 2 149 patients received transfusion therapy, of whom 63,1 % were male and 36,9% female, with a median age of 65 years.. The average hematocrit was 024. Units of blood transfused were 4 440: 3 421 units of packed red blood cells (77 %), 684 units of platelet concentrate (15,4 %), 322 units of fresh frozen plasma (7,3 %) and 13 cryoprecipitate units (0,3 %). The average number of units transfused per patient was 2.5. There was a higher consumption by clinical specialties (55,6 %) than by surgical (44,4 %). Only 14 post-transfusion reactions (0,7 %) were reported.
Conclusions: we consider that there was an appropriate use of blood and blood components but we must continue working to reduce the transfusion threshold and in the detection of adverse reactions.


REFERENCES

  1. Shander A, Hofmann A, Isbister J, Van Aken H. Patient blood management - the new frontier. Best Pract Res Clin Anaesthesiol. 2013;27:5-10.

  2. Shander A, Gross I, Hill S, Javidroozi M, Sledge S. A new perspective on best transfusion practices. Blood Transfus. 2013;11:193-202. DOI: 10.2450/2012.0195-12.

  3. Bagang E, Szallasi A. Transfusion indication RBC (PBM-02): gap analysis of a Joint Commission Patient Blood Management Performance Measure at a community hospital. Blood Transfus. 2014;12 (Suppl 1): s187-90. DOI:10.2450/2012.0088-12.

  4. Ali A, Auvinen MK, Rautonen J. The aging population poses a global challenge for blood services. Transfusion. 2010;50:584–8.

  5. Barr PJ, Donnelly M, Cardwell CR. The appropriateness of red blood cell use and the extent of overtransfusion:right decision? Right amount? Transfusion. 2011;51:1684-94.

  6. OPS-OMS. Recomendaciones para la estimación de las necesidades de sangre y sus componentes. Washington DC:OPS;2010.

  7. Pérez-Ulloa LE, Rubio-Rubio R, Suárez-Escandón A, Cádiz-Lahens A, Ballester- Santovenia JM. Breve análisis del comportamiento de la hemoterapia en Cuba en el año 2011. Rev Cubana Hematol Inmunol Hemoter. 2012;28(4):435-8.

  8. Bosch MLA. Un análisis crítico de quien y cuando transfundimos. Rev Mex Med Tran. 2010;3:22-9.

  9. Greinacher A, Fendrich K, Hoffmann W. Demographic changes:the impact for safe blood supply. Transfus Med Hemother. 2010;37:141–8.

  10. Barr PJ, Donnelly M, Morris K. The epidemiology of red cell transfusion. Vox Sang. 2010;99:239–50.

  11. Biggin K, Warner P, Prescott R. A review of methods used in comprehensive, descriptive studies that relate red blood cell transfusion to clinical data. Transfusion. 2010;50(3):711–8.

  12. Guralnik JM, Eisenstaedt RS, Ferrucci L. Prevalence of anemia in persons 65 years and older in the United States: evidence of a high rate of unexplained anemia. Blood. 2004;104:2263–8.

  13. Goodnough LT. Blood management: transfusion medicine comes of age. Lancet. 2013;381:1791-2.

  14. Katalinic A, Peters E, Beske F. Projection of morbidity 2030 and 2050: impact for the national health system and blood supply. Transfus Med Hemother. 2010;37:155–59.

  15. Revelan datos preliminares del Censo de Población y Viviendas 2012. Granma. 2012 Diciembre 7;7:38:14.

  16. Theusinger O, Kind S, Seifert B, Borgeat A, Gerber C, Spahn D. Patient blood management in orthopaedic surgery:a four-year follow-up of transfusion requirements and blood loss from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland. Blood Transfus. 2014;12:195-203. DOI:10.2450/2014.0306-13.

  17. Seifried E, Klueter H, Weidmann C, Staudenmaier T, Schrezenmeier H, Henschler R et al. How much blood is needed? Vox Sanguinis. 2011;100:10–21.

  18. Cooper HA, Rao SV, Greenberg MD. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol. 2011;108:1108-11.

  19. Verlicchi F, Facco G, Macrì M, Antoncecchi S, Bonomo P. Blood transfusion practice: a nationwide survey in Italy Blood Transfus. 2011;9:430-5. DOI:10.2450/2011.0023-10.

  20. Liumbruno GM, Bennardello F, Lattanzio A. Recommendations for the transfusion management of patients in the peri-operative period. II. The intraoperative period. Blood Transfus. 2011;9:189-217.

  21. Kozek-Langenecker SA, Afshari A, Albaladejo P. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30:270-382.

  22. Grey DE, Finlayson J. Red cell transfusion for iron-deficiency anaemia: a retrospective audit at a tertiary hospital. Vox Sanguinis. 2008;94:138–42.

  23. Bagang E, Szallasi A. "Transfusion indication RBC (PBM-02)": gap analysis of a Joint Commission Patient Blood Management Performance Measure at a community hospital. Blood Transfus. 2014;12(Suppl 1): s187-90. DOI:10.2450/2012.0088-12.

  24. Roback JD, Caldwell S, Carson J. Evidence based practice guidelines for plasma transfusion. Transfusion. 2010;50:1227-39.

  25. World Health Organization: 10 facts on blood transfusion [document on the Internet]. WHO 2009 June 14 [accessed 2010 June 3]. Disponible en:http://www.who.int/bloodsafety/FactFile 2009.pdf

  26. Borkent-Raven BA, Janssen MP, van der Poel CL, et al. The PROTON study: profiles of blood product transfusion recipients in the Netherlands. Vox Sanguinis. 2010;99:54–64.

  27. Isbister JP, Shander A, Spahn DR. Adverse blood transfusion outcomes: establishing causation. Transfus Med Rev. 2011;25:89-101.

  28. Mountford J, Olivier E, Turner M. Prospects for the manufacture of red cells for transfusion. Br J Haematol. 2010;149:22–34.

  29. Anderson SA, Menis M, O’Connell K. Blood use by inpatient elderly population in the United States. Transfusion. 2007;47:582–92.

  30. Spahn DR, Goodnough LT. Alternatives to blood transfusion. Lancet. 2013;381:1855-65.

  31. Greinacher A, Fendrich K, Hoffmann W. Demographic changes: the impact for safe blood supply. Transfus Med Hemother. 2010;37:141–8.




2020     |     www.medigraphic.com